The marketing authorization holder informed its supplied customers in a letter dated August 16, 2018, that due to quality problems with one batch of ampoules, batch D1K13 is being recalled as a precautionary measure.
|Name of the medicinal product||Robinul 0,2 mg - Ampullen|
|Marketing authorisation number(s)||1-18081|
|Marketing authorisation holder||Chiesi Pharmaceuticals GmbH|
|Classification of the recall||1|
|BASG reference number||INS-640.001-2611|